Jolanta Białkowska

Medical University of Warsaw

H指数:16

被引数:1,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Digit ratios and hospitalization for COVID-19: A test of the low-androgen-driven and high-androgen-driven theories of COVID-19 severity

ANDROLOGY

IF3.4

2024-07-290

PRE

Effectiveness of pangenotypic retreatment of chronic hepatitis C after prior failure of pangenotypic therapies

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2023-01-053

Right-left digit ratios, a novel form of asymmetry: Patterns of instability in children and relationships to platelet counts and hospitalization in adults with COVID-19

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-10-142

OAAI

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-09-018

OAAI

Rajewski, Pawel; Zarebska-Michaluk, Dorota; Janczewska, Ewa; Gietka, Andrzej; Mazur, Wlodzimierz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Dybowska, Dorota; Halota, Waldemar; Lorenc, Beata; Sitko, Marek; Garlicki, Aleksander; Berak, Hanna; Horban, Andrzej; Orlowska, Iwona; Simon, Krzysztof; Socha, Lukasz; Wawrzynowicz-Syczewska, Marta; Jaroszewicz, Jerzy; Deron, Zbigniew; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Krygier, Rafal; Piekarska, Anna; Laurans, Lukasz; Dobracki, Witold; Bialkowska, Jolanta; Tronina, Olga; Wietlicka-Piszcz, Magdalena; Pawlowska, Malgorzata; Flisiak, Robert

Digit ratios and their asymmetries as risk factors of developmental instability and hospitalization for COVID-19 (Mar, 10.1038/s41598-022-08646-7, 2022)

数字比率及其不对称性是新型冠状病毒肺炎发育不稳定和住院的危险因素 (3月，10.1038/s41598-022-08646-7，2022)

SCIENTIFIC REPORTS

IF3.9

2022-05-230

OAAI

Digit ratios and their asymmetries as risk factors of developmental instability and hospitalization for COVID-19

SCIENTIFIC REPORTS

IF3.9

2022-03-175

OAAI

HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-01-134

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-07-2517

OAAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Parfieniuk-Kowerda, Anna; Janczewska, Ewa; Dybowska, Dorota; Pawlowska, Malgorzata; Halota, Waldemar; Mazur, Wlodzimierz; Lorenc, Beata; Janocha-Litwin, Justyna; Simon, Krzysztof; Piekarska, Anna; Berak, Hanna; Klapaczynski, Jakub; Stepien, Piotr; Sobala-Szczygiel, Barbara; Citko, Jolanta; Socha, Lukasz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Dobracka, Beata; Krygier, Rafal; Bialkowska-Warzecha, Jolanta; Laurans, Lukasz; Flisiak, Robert

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2021-05-1411

OAAI

Janczewska, Ewa; Kolek, Mateusz Franciszek; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Zarebska-Michaluk, Dorota; Buczynska, Iwona; Dybowska, Dorota; Czau-Anderzejuk, Agnieszka; Berak, Hanna; Krygier, Rafal; Jaroszewicz, Jerzy; Citko, Jolanta; Piekarska, Anna; Dobracka, Beata; Socha, Lukasz; Deron, Zbigniew; Laurans, Lukasz; Bialkowska-Warzecha, Jolanta; Tronina, Olga; Adamek, Brygida; Tomasiewicz, Krzysztof; Simon, Krzysztof; Pawlowska, Malgorzata; Halota, Waldemar; Flisiak, Robert

Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study

肝硬化和肝功能失代偿史患者直接抗病毒药物的真实世界有效性和安全性: Epi-Ter2研究

LIVER INTERNATIONAL

IF5.2

2021-03-1818

PREAI

Berkan-Kawinska, Aleksandra; Piekarska, Anna; Janczewska, Ewa; Lorenc, Beata; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Berak, Hanna; Horban, Andrzej; Zarebska-Michaluk, Dorota; Pabjan, Pawel; Buczynska, Iwona; Pazgan-Simon, Monika; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Klapaczynski, Jakub; Mazur, Wlodzimierz; Czau(z) over dot-Andrzejuk, Agnieszka; Socha, Lukasz; Laurans, Lukasz; Garlicki, Aleksander; Sitko, Marek; Jaroszewicz, Jerzy; Citko, Jolanta; Dobracka, Beata; Krygier, Rafal; Bialkowska-Warzecha, Jolanta; Tronina, Olga; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Flisiak, Robert

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?

在现实世界中，格列卡普雷韦/皮布伦他韦的8周治疗方案是否足以满足所有感染丙型肝炎病毒的患者？

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2020-11-2311

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Pabjan, Pawel; Lapinski, Tadeusz W.; Mazur, Wlodzimierz; Krygier, Rafal; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Janczewska, Ewa; Buczynska, Iwona; Simon, Krzysztof; Dobracka, Beata; Citko, Jolanta; Laurans, Lukasz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Piekarska, Anna; Sitko, Marek; Bialkowska-Warzecha, Jolanta; Klapaczynski, Jakub; Sobala-Szczygiel, Barbara; Horban, Andrzej; Berak, Hanna; Deron, Zbigniew; Lorenc, Beata; Socha, Lukasz; Tronina, Olga; Flisiak, Robert

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2020-06-2714

PREAI

Jaroszewicz, Jerzy; Pawlowska, Malgorzata; Simon, Krzysztof; Zarebska-Michaluk, Dorota; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Janczewska, Ewa; Paluch, Katarzyna; Dybowska, Dorota; Buczynska, Iwona; Czauz-Andrzejuk, Agnieszka; Berak, Hanna; Krygier, Rafal; Piasecki, Maciej; Dobracka, Beata; Citko, Jolanta; Piekarska, Anna; Socha, Lukasz; Deron, Zbigniew; Tronina, Olga; Laurans, Lukasz; Bialkowska, Jolanta; Tomasiewicz, Krzysztof; Halota, Waldemar; Flisiak, Robert

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2020-02-0724

Flisiak, Robert; Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Janczewska, Ewa; Pabjan, Pawel; Dybowska, Dorota; Buczynska, Iwona; Czauz-Andrzejuk, Agnieszka; Belica-Wdowik, Teresa; Berak, Hanna; Krygier, Rafal; Piasecki, Maciej; Dobracka, Beata; Citko, Jolanta; Piekarska, Anna; Socha, Lukasz; Deron, Zbigniew; Tronina, Olga; Laurans, Lukasz; Bialkowska, Jolanta; Tomasiewicz, Krzysztof; Halota, Waldemar; Simon, Krzysztof; Pawlowska, Malgorzata

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously difficult to treat patients infected with hepatitis C virus genotype 1 and 4

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2020-01-169

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Buczynska, Iwona; Simon, Krzysztof; Lorenc, Beata; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Garlicki, Aleksander; Janczewska, Ewa; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Pabjan, Pawel; Mazur, Wlodzimierz; Czauz-Andrzejuk, Agnieszka; Berak, Hanna; Horban, Andrzej; Socha, Lukasz; Klapaczynski, Jakub; Piekarska, Anna; Blaszkowska, Maria; Belica-Wdowik, Teresa; Dobracka, Beata; Tronina, Olga; Deron, Zbigniew; Bialkowska-Warzecha, Jolanta; Laurans, Lukasz; Flisiak, Robert

Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C

ARCHIVES OF MEDICAL SCIENCE

IF3.3

2020-01-013

OAAI

Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Jakub, Klapaczynski; Mazur, Wlodzimierz; Krygier, Rafal; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Janczewska, Ewa; Pabjan, Pawel; Dobracka, Beata; Lorenc, Beata; Tudrujek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Garlicki, Aleksander; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Laurans, Lukasz; Zbigniew, Deron; Orlowska, Iwona; Krzysztof, Simon; Bialkowska-Warzecha, Jolanta; Olga, Tronina; Flisiak, Robert

Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Low risk of HBV reactivation in a large European cohort of HBV/HCV coinfected patients treated with DAA

JOURNAL OF HEPATOLOGY

IF33

2019-04-011

PREAI

Jaroszewicz, Jerzy; Piasecki, Maciej; Lorenc, Beata; Buczynska, Iwona; Krzysztof, Simon; Zarebska-Michaluk, Dorota; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Garlicki, Aleksander; Belica-Wdowik, Teresa; Janczewska, Ewa; Dobracka, Beata; Tudrujek, Magdalena; Tomasiewicz, Krzysztof; Berak, Hanna; Mazur, Wlodzimierz; Olga, Tronina; Jakub, Klapaczynski; Krygier, Rafal; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Socha, Lukasz; Piekarska, Anna; Zbigniew, Deron; Bialkowska-Warzecha, Jolanta; Flisiak, Robert

The efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

BMC INFECTIOUS DISEASES

IF3

2018-11-162

OAAI

Janczewska, Ewa; Zarebska-Michaluk, Dorota; Berak, Hanna; Piekarska, Anna; Gietka, Andrzej; Dybowska, Dorota; Mazur, Wlodzimierz; Belica-Wdowik, Teresa; Dobracki, Witold; Tudrujek-Zdunek, Magdalena; Deron, Zbigniew; Buczynska, Iwona; Sitko, Marek; Czauz-Andrzejuk, Agnieszka; Lorenc, Beata; Bialkowska-Warzecha, Jolanta; Citko, Jolanta; Laurans, Lukasz; Jaroszewicz, Jerzy; Socha, Lukasz; Tronina, Olga; Adamek, Brygida; Horban, Andrzej; Halota, Waldemar; Baka-Cwierz, Barbara; Tomasiewicz, Krzysztof; Simon, Krzysztof; Garlicki, Aleksander; Wawrzynowicz-Syczewska, Marta; Flisiak, Robert

The efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

JOURNAL OF HEPATOLOGY

IF33

2018-04-010

PREAI

Janczewska, E.; Flisiak, R.; Zarebska-Michaluk, D.; Arkadiusz, P.; Staniaszek, A.; Gietka, A.; Mazur, W.; Tudrujek, M.; Tomasiewicz, K.; Belica-Wdowik, T.; Baka-Cwierz, B.; Dybowska, D.; Halota, W.; Lorenc, B.; Sitko, M.; Garlicki, A.; Berak, H.; Andrzej, H.; Orlowska, I.; Krzysztof, S.; Socha, L.; Wawrzynowicz-Syczewska, M.; Jaroszewicz, J.; Zbigniew, D.; Czauz-Andrzejuk, A.; Citko, J.; Krygier, R.; Piekarska, A.; Laurans, L.; Dobracka, B.; Bialkowska-Warzecha, J.; Olga, T.; Pawlowska, M.

Jolanta Białkowska

个人简介

教育背景

工作经历

荣誉奖项

研究方向